BMO Capital Markets reaffirmed their Outperform rating on Beam Therapeutics Inc (NASDAQ:BEAM), with a steady price target of $57.00. Currently trading at $26.57, the stock appears undervalued ...

BMO today announced it has joined the IBM Quantum Network, extending its technology leadership in North America to further drive real financial progress for its customers, clients, and the communities ...

Operational resilience has become crucial for financial institutions navigating today's digital landscape riddled with cyber ...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICATORONTO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- ...

WEC Energy Group (NYSE:WEC – Free Report) had its price target increased by BMO Capital Markets from $95.00 to $100.00 in a research note released on Wednesday morning,Benzinga reports. BMO Capital ...

Robert W. Baird reiterated their neutral rating on shares of Paycor HCM (NASDAQ:PYCR – Free Report) in a report issued on ...

BMO Capital Markets updated its outlook on Fiserv (NYSE:FI) shares, raising the price target to $260 from the previous $233, while reiterating an Outperform rating. The adjustment follows Fiserv's ...

Financial services, and especially financial advising, have historically been male dominated, but Nigerian women’s financial ...

CEO Bourla sees "a lot of opportunities that probably outweigh the risks" with the Trump administration, like working together on cancer treatments ...

Highlights,Primerica, (NYSE:PRI),has received updated ratings from multiple financial firms, reflecting varied perspectives ...

The ASX dropped 0.3% this morning, with mood in the market dampening after a rise in US job growth and President Trump's ...

Highlights,BMO Capital Markets reduces Ingredion's target price from $147.00 to $133.00, reflecting recent ...